Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 October 2023 | Story Dr Kwazi Magwenzi | Photo supplied
SANRAL Chair launch
The SANRAL Chair in Mathematics and Science , Prof Loyiso Jita with the Programme graduates, the PhD and Masters SANRAL Alumni at the event held on 28 September 2023 in Johannesburg, South Africa.

The South African Chapter of the South African National Roads Agency Limited (SANRAL) Chair alumni programme at the University of the Free State (UFS) was recently launched at the Silverstar Hotel and Casino in Johannesburg. The event aimed to showcase and celebrate the achievements made and lessons learnt in the programme, highlight the key elements and outputs to the Faculty of Education stakeholders and reimagine the future. The Faculty of Education has increased its footprint in Engaged Scholarship activities, aligning itself with the UFS Vision 130. Multiple stakeholders and community partners were invited to witness the outstanding achievements of this programme.

Since its inception in 2014, the SANRAL Chair has produced over 40 PhD graduates in three countries, namely South Africa, Lesotho, and Zimbabwe. One of the key goals of Vision 130 is for the UFS to be regionally engaged and to contribute to pressing societal needs. This involves knowledge generation that contributes to local and regional development and building sustainable partnerships. The PhD and Masters graduates have become a highly valued human resource in the South African education system and the region, and are now positioned as leaders in Institutions of higher learning in South Africa, Lesotho, and Zimbabwe.

The SANRAL Chair currently supervises a cohort of doctoral and master's students,  providing guidance in mathematical research and publications. The internship programme represents SANRAL's commitment to building skilled capacity in communities, along with driving social and economic transformation. SANRAL has also identified common challenges faced by Small, Medium, and Micro-sized Enterprises (SMMEs) in its projects and has implemented training programmes to address these issues. 

South Africa has implemented a range of programmes designed to achieve Sustainable Development Goal 1 (SDG 1), which includes land reform, agriculture, free higher education and growth. Despite the significant progress made on South Africa’s developmental journey since the advent of democracy in 1994, the country remains one of the most unequal societies in the world. Achieving the SDGs is, therefore, in South Africa’s best interest as the country pursues the vision of a united, non-racial, non-sexist, and prosperous nation living in harmony with itself and the rest of the world. 

As South Africa looks ahead to 2030, it seeks to build on the substantial progress achieved thus far, and on the robust policy, legislative, and planning foundation. The focus will be on consolidating and expanding the many areas where public welfare and development are at the forefront. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept